DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Savarino E, Bodini G, Dulbecco P et al.
Adalimumab Is More Effective Than Azathioprine and Mesalamine at Preventing Postoperative Recurrence of Crohn's Disease: A Randomized Controlled Trial.
American Journal of Gastroenterology 2013;
108: 1731-1742
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.